Edan Instruments, Inc. (SHE:300206)

Market Cap	8.42B +35.2%
Revenue (ttm)	1.90B +5.7%
Net Income	246.84M +57.8%
EPS	0.43 +57.8%
Shares Out	579.66M
PE Ratio	34.12
Forward PE	n/a
Dividend	0.21 (1.41%)
Ex-Dividend Date	May 27, 2025

Volume	5,403,100
Average Volume	12,699,282
Open	14.61
Previous Close	14.64
Day's Range	14.52 - 14.75
52-Week Range	9.55 - 16.80
Beta	0.57
RSI	51.25
Earnings Date	Mar 31, 2026

About Edan Instruments

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic d...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,546
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300206

Financial Performance

In 2024, Edan Instruments's revenue was 1.83 billion, a decrease of -5.35% compared to the previous year's 1.94 billion. Earnings were 162.11 million, a decrease of -26.75%.